MDxHealth (MDXH) Other Non-Current Liabilities (2020 - 2026)
MDxHealth (MDXH) posted Other Non-Current Liabilities of $136.2 million for Q2 2025, little changed sequentially from $135.9 million in Q4 2024, and up 1.72% YoY from $133.9 million in Q2 2024.
MDxHealth (MDXH) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
MDxHealth has reported Other Non-Current Liabilities for 5 years, with the latest figure at $136.2 million in Q2 2025.
- Quarterly Other Non-Current Liabilities rose 1.72% year-over-year to $136.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $136.2 million (up 1.72% YoY) and the FY2025 annual result came in at $136.2 million, changed N/A from the prior year.
- Other Non-Current Liabilities was little changed at $136.2 million in Q2 2025 per MDXH's latest filing, from $135.9 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $136.2 million in Q2 2025 and troughed at $25.4 million in Q4 2021.
- A 5-year average of $98.9 million and a median of $113.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities soared 319.02% in 2023, then climbed 1.72% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $25.4 million in 2021, then soared by 316.05% to $105.8 million in 2022, then climbed by 9.82% to $116.2 million in 2023, then advanced by 16.94% to $135.9 million in 2024, then advanced by 0.23% to $136.2 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $136.2 million, $135.9 million, and $133.9 million for Q2 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | MDxHealth | 36.03 Mn | 15.62 Mn | 17.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.05 Mn |
| Mar 31, 2026 | 35.35 Mn |
| Dec 31, 2025 | 25.81 Mn |
| Sep 30, 2025 | 25.44 Mn |
| Jun 30, 2025 | 24.51 Bn |
| Mar 31, 2025 | 43.28 Mn |
| Dec 31, 2024 | 27.10 Mn |
| Sep 30, 2024 | 41.46 Mn |
| Jun 30, 2024 | 40.25 Mn |
| Mar 31, 2024 | 64.88 Mn |
| Dec 31, 2023 | 41.18 Mn |
| Sep 30, 2023 | 60.34 Mn |
| Jun 30, 2023 | 35.90 Mn |
| Dec 31, 2022 | 35.17 Mn |
| Sep 30, 2022 | 44.92 Mn |
| Jun 30, 2022 | 44.90 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Dec 31, 2020 | 504,344.99 |